reference/33515362

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33515362

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.\|Research Support, U.S. Gov't, P.H.S.
endingPage	2577
issn	1078-0432 1557-3265
issueIdentifier	7
pageRange	2570-2577
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	2570
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_15ef49b3224a682caeb3c4f0ee0e26b6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4a94d5c841561fdd45e7bb0d36113796 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a2566f3012529d7315cce52d218b6759
bibliographicCitation	Dragnev KH, Pitha-Rowe I, Ma Y, Petty WJ, Sekula D, Murphy B, Rendi M, Suh N, Desai NB, Sporn MB, Freemantle SJ, Dmitrovsky E. Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy. Clin Cancer Res. 2004 Apr 01;10(7):2570–7. doi: 10.1158/1078-0432.ccr-03-0271. PMID: 15073138.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48698b7c861ae1f0646b6ef4592a3308 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fd27b54ad36eaa12e5ae44385e8c7f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_663336139a29ac422d57f207cae10f01 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f622e02744cdd38285ebcfae4af5ac04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3b892ec923b3ee040e387634cacab09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1426-5013 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77870f762291a49e4a6fa603ee62531e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23e6ea680cd6550eabb217f61bf949f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_956fe282d48b26b0b7d0593e7966b955 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f2df75b60e9bb9c8bc5d77310de2e0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ee23564a2fc955f161df2f6fce7fd48 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28c669101ab698f32834f1973ffc618f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_90e2b78e9927cf70780949c8b04c1488
date	2004-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15073138 https://doi.org/10.1158/1078-0432.ccr-03-0271
isPartOf	https://portal.issn.org/resource/ISSN/1557-3265 https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Specific Chemopreventive Agents Trigger Proteasomal Degradation of G1 Cyclins: Implications for Combination Therapy
discusses	http://id.nlm.nih.gov/mesh/M0140424 http://id.nlm.nih.gov/mesh/M0529100 http://id.nlm.nih.gov/mesh/M0025302 http://id.nlm.nih.gov/mesh/M0018962 http://id.nlm.nih.gov/mesh/M0012428 http://id.nlm.nih.gov/mesh/M0560885 http://id.nlm.nih.gov/mesh/M0029602 http://id.nlm.nih.gov/mesh/M0174711 http://id.nlm.nih.gov/mesh/M0029612 http://id.nlm.nih.gov/mesh/M0024762 http://id.nlm.nih.gov/mesh/M0528982 http://id.nlm.nih.gov/mesh/M0021415 http://id.nlm.nih.gov/mesh/M0021879 http://id.nlm.nih.gov/mesh/M0489139
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016588Q000627 http://id.nlm.nih.gov/mesh/D046988Q000378 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D016213Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001980Q000166 http://id.nlm.nih.gov/mesh/D009154 http://id.nlm.nih.gov/mesh/D007976Q000494 http://id.nlm.nih.gov/mesh/D004249 http://id.nlm.nih.gov/mesh/D020133 http://id.nlm.nih.gov/mesh/D002455 http://id.nlm.nih.gov/mesh/D061988 http://id.nlm.nih.gov/mesh/D002460 http://id.nlm.nih.gov/mesh/D018929 http://id.nlm.nih.gov/mesh/D056746 http://id.nlm.nih.gov/mesh/D004847Q000378 http://id.nlm.nih.gov/mesh/D013912Q000737 http://id.nlm.nih.gov/mesh/D019927Q000378 http://id.nlm.nih.gov/mesh/D012176Q000737 http://id.nlm.nih.gov/mesh/D019938Q000378 http://id.nlm.nih.gov/mesh/D019938Q000096 http://id.nlm.nih.gov/mesh/D015151 http://id.nlm.nih.gov/mesh/D056766 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D014212Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014162 http://id.nlm.nih.gov/mesh/D014158 http://id.nlm.nih.gov/mesh/D016193
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_38ca895fb47c55c08b93484274f41182 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15308217 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451674 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a95421c679462609c9ef4e68005e1dcc http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6915732 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6288 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75b1cb2b3111061c7bf9fd1929c12890 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288209 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24896136

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129235852 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127863084 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127476202 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127984794 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127419321

Total number of triples: 98.